Advertisement
Advertisement
U.S. Markets close in 1 hr 57 mins
Advertisement
Advertisement
Advertisement
Advertisement

Poolbeg Pharma PLC (POLB.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
Add to watchlist
4.7000+0.0500 (+1.08%)
At close: 04:33PM BST
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close4.6500
Open4.6000
Bid4.5000 x N/A
Ask4.9000 x N/A
Day's Range4.5000 - 4.9000
52 Week Range4.1340 - 13.3000
Volume561,567
Avg. Volume1,592,067
Market Cap23.5M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est15.00
  • ACCESSWIRE

    Poolbeg Pharma PLC Announces Appointment of Joint Broker

    July 29, 2022 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF) ('Poolbeg' or the 'Company'), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, has appointed Singer Capital Markets as Joint Broker with immediate effect. finnCap Ltd will continue to act as Nominated Adviser and Joint Broker alongside J&E Davy as additional Joint Broker.

  • ACCESSWIRE

    Poolbeg Pharma PLC Announces POLB001 Human Challenge Clinical Trial To Commence

    Poolbeg Pharma (Poolbeg Pharma plc) (AIM:POLB)(OTCQB:POLBF), ('Poolbeg' or the 'Company'), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, has received ethics and competent authority approval to commence its Lipopolysaccharide (LPS) human challenge clinical trial for POLB 001, a strain agnostic, small molecule immunomodulator which aims to address the unmet medical need for a treatment for severe

  • Simply Wall St.

    Here's Why We're Not At All Concerned With Poolbeg Pharma's (LON:POLB) Cash Burn Situation

    Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Advertisement
Advertisement